These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 11723273)

  • 21. Subthalamic nucleus deep brain stimulation improves dyskinesias in Parkinson's disease beyond levodopa reduction.
    Mossner JM; Patil PG; Chou KL
    J Neural Transm (Vienna); 2019 Nov; 126(11):1479-1483. PubMed ID: 31494731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
    Nutt JG; Carter JH; Carlson NE
    Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain penetration effects of microelectrodes and DBS leads in STN or GPi.
    Mann JM; Foote KD; Garvan CW; Fernandez HH; Jacobson CE; Rodriguez RL; Haq IU; Siddiqui MS; Malaty IA; Morishita T; Hass CJ; Okun MS
    J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):794-7. PubMed ID: 19237386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review.
    Ghika J; Villemure JG; Fankhauser H; Favre J; Assal G; Ghika-Schmid F
    J Neurosurg; 1998 Nov; 89(5):713-8. PubMed ID: 9817406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease.
    Krack P; Pollak P; Limousin P; Hoffmann D; Xie J; Benazzouz A; Benabid AL
    Brain; 1998 Mar; 121 ( Pt 3)():451-7. PubMed ID: 9549521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which target for DBS in Parkinson's disease? Subthalamic nucleus versus globus pallidus internus.
    Scotto di Luzio AE; Ammannati F; Marini P; Sorbi S; Mennonna P
    Neurol Sci; 2001 Feb; 22(1):87-8. PubMed ID: 11487215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease.
    Kumar R; Lozano AM; Montgomery E; Lang AE
    Mov Disord; 1998; 13 Suppl 1():73-82. PubMed ID: 9613722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation.
    Moro E; Esselink RJ; Benabid AL; Pollak P
    Brain; 2002 Nov; 125(Pt 11):2408-17. PubMed ID: 12390968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson's Disease.
    Samura K; Miyagi Y; Kawaguchi M; Yoshida F; Okamoto T; Kawashima M
    Neurol Med Chir (Tokyo); 2019 Sep; 59(9):331-336. PubMed ID: 31231086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease.
    St George RJ; Carlson-Kuhta P; Burchiel KJ; Hogarth P; Frank N; Horak FB
    J Neurosurg; 2012 Jun; 116(6):1347-56. PubMed ID: 22424564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson's disease.
    Evidente VG; Premkumar AP; Adler CH; Caviness JN; Driver-Dunckley E; Lyons MK
    Acta Neurol Scand; 2011 Sep; 124(3):211-4. PubMed ID: 20969559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations.
    Østergaard K; Sunde N; Dupont E
    Mov Disord; 2002 Jul; 17(4):693-700. PubMed ID: 12210858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.
    Mansouri A; Taslimi S; Badhiwala JH; Witiw CD; Nassiri F; Odekerken VJJ; De Bie RMA; Kalia SK; Hodaie M; Munhoz RP; Fasano A; Lozano AM
    J Neurosurg; 2018 Apr; 128(4):1199-1213. PubMed ID: 28665252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rescue levodopa-carbidopa intestinal gel (LCIG) therapy in Parkinson's disease patients with suboptimal response to deep brain stimulation.
    Elkouzi A; Ramirez-Zamora A; Zeilman P; Barabas M; Eisinger RS; Malaty IA; Okun MS; Almeida L
    Ann Clin Transl Neurol; 2019 Oct; 6(10):1989-1995. PubMed ID: 31518070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation.
    Rodriguez-Oroz MC; Zamarbide I; Guridi J; Palmero MR; Obeso JA
    J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1382-5. PubMed ID: 15377681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias?
    Minguez-Castellanos A; Escamilla-Sevilla F; Katati MJ; Martin-Linares JM; Meersmans M; Ortega-Moreno A; Arjona V
    J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):34-9. PubMed ID: 15607992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.